About Us

The Department of Oncology is a clinical and basic sciences department created in 1993 that provides a focus for cancer-related teaching and research. The Department is based at the Cross Cancer Institute (CCI), a tertiary cancer facility, operated by the Alberta Health Services that provides cancer services for northern Alberta. Dr. Tony Fields was appointed as the Acting Chair in 1993.  Dr. Carol Cass was appointed as Chair of Oncology in 1996 and continued in this role until June 30, 2007.  The success of the Department has been achieved through the leadership of Dr. Fields and Dr. Cass.  The Department has grown from 25 primary academic staff in 1993 to 105 in 2010.  Research funding awarded to academic staff in Oncology has increased from $4M in 1993 to $18.6M in 2010.
The Department has seven academic divisions: Experimental Oncology, Medical Oncology, Medical Physics, Oncologic Imaging, Palliative Care Medicine, Radiation Oncology, and Surgical Oncology. There are 105 full-time members of the Department and 44 adjunct members.   
Six of the Divisions are comprised of faculty members who are clinicians or service professionals in applied disciplines and one, the Division of Experimental Oncology, is comprised of basic scientists engaged in discovery and translational cancer research.
The Department offers postgraduate residency training in medical oncology, radiation oncology, palliative care medicine, and medical physics, graduate and postdoctoral training in experimental oncology and in collaboration with the Department of Physics in medical physics. An internship in clinical psychology is offered by members of Palliative Care Medicine in collaboration with the Department of Educational Psychology. A technical training program in radiation therapy is offered by members of Radiation Oncology, Medical Physics and Experimental Oncology.
The Department of Oncology has a substantial and broad portfolio of peer-reviewed cancer research support with scientific and clinical staff engaged in multidisciplinary research efforts in discovery, translational, clinical and population-based research.   Over the years we have successfully built a research infrastructure to support our activities which include nationally and internationally recognized multi-user facilities based on the newest technologies and a clinical trials infrastructure that supports Phase I, cooperative group, investigator-initiated and industry sponsored trials.